20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with u 0126 in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (u 0126) | Trials (u 0126) | Recent Studies (post-2010) (u 0126) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 2,816 | 2 | 1,213 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | u 0126 (IC50) |
|---|---|---|---|
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.29 | |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.25 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.07 | |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 0.2816 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.2529 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, PA; Falck, JC; Guo, AM; Scicli, AG; Scicli, G; Sheng, J | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and u 0126
| Article | Year |
|---|---|
20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells.
Topics: Butadienes; Capillaries; Cells, Cultured; Dermis; Endothelial Cells; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hydroxyeicosatetraenoic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidases; Nitric Oxide Synthase; Nitriles; RNA, Small Interfering; Superoxides; Vascular Endothelial Growth Factor A | 2009 |